29 October 2021
PRESS RELEASE
BioMAdvanced Diagnostics has selected the company IDBC (A2Com Group) to develop the processing of the digital part of its developing offer. IDBC has accepted the challenge, drawing on its experience of supporting its clients (hospitals, research physicians, biostatisticians, etc.) in the successful completion of their projects around health data. IDBC has developed a suite of services for patient monitoring and research, from study design to data analysis, including for publication. IDBC is licensed as a Health Data Host (HDS) and is ISO-27001 certified to ensure data security. BioMAdvanced Diagnostics has been particularly sensitive to the detailed needs analysis and its way of working. The next steps will include shaping a digital interface fully adapted to the needs of BioMAdvanced Diagnostics customers by visually and synthetically transcribing the most relevant information.
